A shadow market for unapproved weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.
Investigational Drug Gaining Popularity Via Social Media
The experimental drug, which is still in research studies, is being advertised by online personalities for its supposed fat-burning effects. Followers are encouraged to contact these accounts privately for supplier links, while also obtaining promotional offers.
Active Commerce on Messaging Platforms
Additionally, a robust market exists on messaging services, where groups with thousands of members share comparison images, administration instructions and claims of next-day UK delivery. Vendors promote the drug there before redirecting customers to WhatsApp for purchases.
Learning About The Experimental Drug
This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.
Healthcare Professionals Voice Concerns
Nevertheless, doctors and pharmacists have cautions that the sale of what remains an unapproved medication in the United Kingdom is worrisome and could result in users administering products of unknown origin.
Some professionals said the demand for retatrutide could be connected to the rising price of licensed weight loss treatments such as Mounjaro.
Regulatory Position and Enforcement
Marketing retatrutide on TikTok or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Several influencers attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still breach medicines, marketing, and consumer laws, potentially leading to penalties, prosecution or imprisonment.
Platform Reaction and Content Elimination
Based on the social media company, the service has removed violative material and prohibited associated keywords and query recommendations. The company said it was committed to maintaining the platform secure and investing in enhancing compliance measures.
Online Marketplace Operations
Research also found groups with up to nine thousand members selling the experimental drug using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately brings up channels with thousands of users, filled with images of weight loss, positive reviews and detailed instructions for mixing or administering at residence.
Within minutes of joining one group, a seller shared WhatsApp details, where most purchases take place. The seller provided an guidebook and guaranteed shipping within two days. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None asked about body mass, medical conditions or past usage.
Product Information and Pricing
Within these groups, messages display black plastic packages with Royal Mail stickers, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at home with purified liquid, or ready-to-use pens typically sold at 160 pounds for 20mg. When questioned how much time a pen should be used, vendors give contradictory answers varying between a several days to “depends on your body”.
Service Oversight and Safety Actions
A spokesperson for the messaging service stated it actively moderated dangerous material on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are administering materials they cannot confirm. Even if the science behind this drug is valid, these online products may not contain what they advertise,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor linked the surge in demand to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With costs increasing, patients are using social media. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the conditions they were made in was sterile,” she said.
Her staff has previously encountered patients harmed by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be impure or incorrectly dosed.”
Manufacturer Statement
A spokesperson from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for human use,” they said, noting that any product “falsely representing itself as a company investigational product not yet authorized … may subject patients to possibly serious health risks”.
